chitosan has been researched along with Infections, Respiratory in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, R; Bebawy, M; De Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Hansbro, PM; Tekade, M; Tekade, RK | 1 |
| Gangadharappa, HV; Mruthunjaya, K; Singh, RP | 1 |
| Almeida, AJ; Alpar, HO; Florindo, HF; Gonçalves, LM; Pandit, S | 1 |
| Cui, F; Huang, J; Huang, Q; Li, G; Lu, M; Lu, W; Zhang, J | 1 |
1 review(s) available for chitosan and Infections, Respiratory
| Article | Year |
|---|---|
Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Topics: Animals; Asthma; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Lung Neoplasms; Nanoparticles; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Respiration Disorders; Respiratory Tract Infections | 2017 |
3 other study(ies) available for chitosan and Infections, Respiratory
| Article | Year |
|---|---|
Phytosome complexed with chitosan for gingerol delivery in the treatment of respiratory infection: In vitro and in vivo evaluation.
Topics: Adult; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Catechols; Chitosan; Drug Carriers; Drug Liberation; Erythrocytes; Escherichia coli; Fatty Alcohols; Humans; Hydrogen Peroxide; Lecithins; Male; Microbial Sensitivity Tests; Particle Size; Picrates; Rabbits; Respiratory Tract Infections; Staphylococcus aureus | 2018 |
Surface modified polymeric nanoparticles for immunisation against equine strangles.
Topics: Adsorption; Alginates; Animals; Bacterial Proteins; Buffers; Cell Wall; Chitosan; Delayed-Action Preparations; Glucuronic Acid; Hexuronic Acids; Horses; Lactic Acid; Magnetic Resonance Spectroscopy; Nanoparticles; Particle Size; Polyesters; Polymers; Polyvinyl Alcohol; Respiratory Tract Infections; Solvents; Static Electricity; Streptococcal Infections; Streptococcal Vaccines; Streptococcus equi | 2010 |
Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream.
Topics: Administration, Intranasal; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Chitosan; Cross Infection; Drug Delivery Systems; Emulsions; Humans; Lysostaphin; Materials Testing; Mice; Mice, Nude; Microbial Sensitivity Tests; Mucociliary Clearance; Nasal Mucosa; Ointment Bases; Petrolatum; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus | 2010 |